Skip to content

AVANIR PHARMACEUTICALS, INC.: filings

Every AVANIR PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 14 filings, each linked to its SEC index.

Filing record ends 2014-12-10

The latest filing in this captured record is a 10-K filed 2014-12-10. No later filing is in the SEC companyfacts record captured on 2026-09-23. AVANIR PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2014-12-10fiscal FY 201433860001193125-14-439125
10-Q2014-08-07fiscal Q3 201429730001193125-14-298755
10-Q2014-05-07fiscal Q2 201432820001193125-14-187139
10-Q2014-02-06fiscal Q1 201431630001193125-14-038532
10-K2013-12-11fiscal FY 201337960001193125-13-468821
10-Q2013-08-08fiscal Q3 201330770001193125-13-326476
10-Q2013-05-09fiscal Q2 201330760001193125-13-208007
10-Q2013-02-08fiscal Q1 201330590001193125-13-045599
10-K2012-12-13fiscal FY 201234890001193125-12-501967
10-Q2012-08-09fiscal Q3 201231790001193125-12-347180
10-Q2012-05-09fiscal Q2 201230760001193125-12-222337
10-Q2012-02-08fiscal Q1 201230610001193125-12-046636
10-K2011-12-13fiscal FY 201132830001193125-11-339193
10-Q2011-08-09fiscal Q3 201130750000950123-11-074991

Inspect the source

Entity
AVANIR PHARMACEUTICALS, INC. / CIK 0000858803
Captured
SEC response SHA-256
4bc74dbc3fac389feeddad4cf6bebf9b8d6610bb15c26be4da3356b3170f82c7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000858803.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))